ZCI
CSTL icon

Zevenbergen Capital Investments’s Castle Biosciences CSTL Stock Holding History

Zevenbergen Capital Investments’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-336,055
Closed -$15.1M – 87
2022
Q1 		$15.1M Sell
336,055
-32,976
-9% -$1.36M 0.41% 35
2021
Q4 		$15.8M Sell
369,031
-155,842
-30% -$8.14M 0.33% 38
2021
Q3 		$34.9M Sell
524,873
-18,053
-3% -$1.27M 0.66% 36
2021
Q2 		$39.8M Buy
542,926
+265,126
+95% +$17.5M 0.71% 37
2021
Q1 		$19M Buy
+277,800
New +$20.9M 0.36% 39

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Zevenbergen Capital Investments's CSTL Position: Q2 2022 in Review

Zevenbergen Capital Investments sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 336,055 shares — an estimated $15.1M sold.

Zevenbergen Capital Investments first reported a position in CSTL in Q1 2021 and held it in 5 quarters. The position peaked at $39.8M in Q2 2021. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • Zevenbergen Capital Investments reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 336,055 Castle Biosciences shares in Q2 2022, an estimated $15.1M.
  • Zevenbergen Capital Investments first reported a position in Castle Biosciences in Q1 2021 and held it in 5 quarters.
  • Zevenbergen Capital Investments's Castle Biosciences position peaked at $39.8M in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on Zevenbergen Capital Investments's 13F filing for Q2 2022, filed 11 Aug 2022.